Back to Results
First PageMeta Content
Microbiology / Millennium Development Goals / Tropical diseases / Infectious diseases / Global health / Global Malaria Action Plan / Medicines for Malaria Venture / DDT / Roll Back Malaria (RBM) Partnership / Medicine / Health / Malaria


Staying the course? F o r m o r e i n f o r m at i o n : PATH Malaria Vaccine Initiative 455 Massachusetts Avenue NW
Add to Reading List

Document Date: 2011-08-01 16:02:08


Open Document

File Size: 2,74 MB

Share Result on Facebook

City

Seattle / Washington / DC / Natal / /

Company

Merck Research Laboratories / MVI Malaria Vaccine Initiative NCE New / Roll Back Malaria Partnership / Associations IMF / RBM Partnership / Immunodeficiency Syndrome IFPMA International Federation of Pharmaceutical Manufacturers / Malaria Venture / Innovative New Diagnostics / ITN / Boston Consulting Group / /

Continent

Africa / Asia / North America / Europe / /

Country

Sri Lanka / Eritrea / /

Currency

USD / /

/

Event

Business Partnership / Diplomatic Relations / FDA Phase / /

/

IndustryTerm

biotechnology / pharmaceutical / chemical entity / vector control products / biological control products / /

MedicalCondition

Roll Back Malaria / summary Malaria / Projected malaria / treatable and preventable disease / Malaria R / malaria PDPs / vicious disease / Disease / Malaria / Top malaria PDP / Infectious Diseases / HIV/AIDS / Massachusetts Avenue NW Malaria / /

NaturalFeature

Eritrea / KwaZulu Natal / Zanzibar / /

Organization

MVI Vaccine Science Portfolio Advisory Committee / National Institute of Health / World Health Organization / International Monetary Fund / Internal Revenue Service / United Nations International Children's Emergency Fund / Malaria R&D Alliance / LSTM Liverpool School / OECD Organisation for Economic Co-operation / US Department of Defense / Tropical Diseases UK United Kingdom US United States USAID US Agency for International Development WHO World Health Organization WHOPES WHO Pesticide Evaluation Scheme WRAIR Walter Reed Army Institute of Research / Melinda Gates Foundation / Tropical Medicine MAEC Spanish Ministry of Foreign Affairs / civil society / World Bank / DOD US Department / Organisation for Economic Co-operation and Development / United Nations Development Programme / FIND Foundation for Innovative New Diagnostics G20 Group of Twenty G8 Group of Eight G-FINDER Global Funding / Neglected Diseases GMP Good Manufacturing Practice GMAP Global Malaria Action Plan HIV/AIDS Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome IFPMA International Federation of Pharmaceutical Manufacturers / Foundation for Innovative New Diagnostics / AS/MQ Artesunate/mefloquine CQ Chloroquine CSR Corporate Social Responsibility DFID UK Department for International Development DGIS Netherlands Directorate-General for International Cooperation DNA Deoxyribonucleic acid DNDi Drugs for Neglected Diseases / /

Person

Cristina Herdman / Javier Guzman / Awa Coll-Seck / Anna Wang / David Kaslow / Katya Spielberg / Nick Chapman / Theresa Raphael / Christian Loucq / Tom McLean / Robert Newman / Awa Marie Coll-Seck / Robert Sloss / Peter Potter-Lesage / Mark Perkins / Iveth Gonzalez / Manny Lewis / Claude Oeuvray / Sally Ethelston / Matthew Doherty / Julia Engelking / Lakshmi Sundaram / Laura Newman / Lisette Abela-Oversteegen / Teri Gilleland Scott / Mary Moran / Ashley Birkett / David Bell / Melanie Wang / Brenda Omune / Dave Simpson / Cornelius Brudi / Andrea Lucard / Jaya Banerji / /

/

Position

manager for this report / Executive Director / Vice President / Vaccines & Infectious Diseases / production manager / consultant / Executive / Chair / Director / Global Malaria Programme / /

Product

mefloquine / Africa / /

ProvinceOrState

Zanzibar / /

Region

Central America / Caribbean / South America / /

Technology

biotechnology / /

SocialTag